Speakers: Dean McKay, PhD, ABPP
CEU(s) Available: 1.0 ACE Event BACB CEUs
Duration: 1 – 60 minute sessions
Modality: On-demand, online, video course.
Abstract: The available research on exposure therapy is primarily based on a model emphasizing habituation. This has served clients well, but clinicians are hesitant to adhere to the core principle of evoking anxiety and holding it until the emotional state recedes. The development of the inhibitory learning model instead emphasizes new learning that competes with the former anxiety-evoking association. The presenter has asserted that, practically speaking, the inhibitory learning approach has actually been the model employed by clinicians who relied on exposure based treatment. This is based on examination of exposure transcripts in therapy guides, where the content shows aspects of expectancy modifications, affect labeling, and other central features of the inhibitory learning approach. Further, inhibitory learning is a more accurate portrayal of how the classical conditioning model was formulated originally by Pavlov. This training session will cover inhibitory learning, and procedures to implement it as a method of exposure treatment for anxiety disorders and other conditions marked by situational avoidance.
Learning Objective 1: Attendees will understand the central components of inhibitory learning approaches to exposure therapy
Learning Objective 2: Attendees will be able to integrate inhibitory learning into cases currently being treated that call for anxiety reduction
Learning Objective 3: Attendees will be able to formulate a wide range of cases marked by avoidance using inhibitory learning methods.
Dean McKay, PhD, ABPP is Professor, Department of Psychology, Fordham University, is Past President (2018) of the Society for a Science of Clinical Psychology (SSCP), and Past-President (2013-2014) of the Association for Behavioral and Cognitive Therapies (ABCT). He serves as a member of the Advisory Board for Better Living Center for Behavioral Health, which specializes in the treatment of anxiety and obsessive compulsive disorders. Dr. McKay is licensed in New York and Connecticut, a member of the National Registry of Healthcare Psychologists, and board certified from the American Board of Professional Psychology (ABPP) in both Cognitive-Behavioral and Clinical Psychology. He has edited or co-edited 22 books, published over 350 journal articles and book chapters, and given over 300 presentations at scientific organizations. In addition to his work on the Advisory Board of Better Living, he is also on the Scientific Advisory Board of the International Obsessive Compulsive Disorder Foundation (IOCDF). Further, he is also a member of the Psychology of Pandemics Workgroup, an international consortium of researchers examining stress-related psychopathology associated with pandemics that was formed in February 2020. Dr. McKay is a Fellow of the American Psychological Association, Association for Psychological Science, and Association for Behavioral and Cognitive Therapies. His research has been primarily obsessive-compulsive and related disorders, anxiety disorders, the role of disgust in psychopathology, and misophonia (selective sound sensitivity), as well as professional issues in the delivery of evidence-based interventions. He has also provided professional consultation and treatment internationally.